July 01, 2025

FDA Approves Low-IgA IG Therapy

GAMMAGARD LIQUID ERC is the first ready-to-use liquid immunoglobulin therapy with IgA ≤2 µg/mL for primary immunodeficiency in individuals aged 2 years and older.

Conexiant

June 30, 2025

Can Typos Change a Diagnosis?

Large language models used in clinical decision-making may offer different treatment recommendations depending on how a patient writes their message—even when the medical facts remain unchanged.

Conexiant

June 27, 2025

Six UGI Patterns Distinguish Neonatal Obstructions

A new research-based review outlines clear imaging patterns and diagnostic strategies to help radiologists quickly identify and manage neonatal bowel obstructions—one of the most common surgical emergencies in newborns.

Conexiant

June 24, 2025

Game-Based Therapy Matches Eye Patching Results

A randomized trial found that a gamified binocular therapy was as effective as patching in treating amblyopia in children, with faster early improvement and better adherence.

Conexiant

June 24, 2025

Is T1b Diabetes Often Genetic?

A review of nearly 300 idiopathic diabetes cases found that about 30% of patients had undiagnosed genetic mutations, raising concerns about misclassification and underuse of comprehensive genetic testing.

Conexiant

June 23, 2025

Fidaxomicin Effective, Well-Tolerated in Pediatric CDI

A multicenter study of pediatric patients treated with fidaxomicin for C difficile found over half were cured by two weeks, and only one in five had a recurrence within two months.

Conexiant

June 23, 2025

Long-Term Declines After Cooling Therapy: Study

A new study tracking children treated with therapeutic hypothermia after birth complications found that many developed motor, cognitive, or behavioral issues by age 10—despite appearing normal in early assessments.

Conexiant

June 20, 2025

Retinal Changes Linked to Neurological Disease Progression

New research reviewed dozens of studies and revealed that visual dysfunction, including retinal changes, may serve as early signs of neurodegenerative and neurodevelopmental diseases, offering a noninvasive pathway for earlier diagnosis and disease monitoring.

Conexiant

June 18, 2025

PFAS Exposure Tied to Adolescent Hypertension

A new study found that prenatal exposure to specific PFAS compounds was associated with higher blood pressure in children and adolescents, with stronger effects observed in boys and Black children.

Conexiant